Millions of books in English, Spanish and other languages. Free UK delivery 

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada peritoneal carcinomatosis: drugs and diseases
Type
Physical Book
Illustrated by
Publisher
Year
2011
Language
English
Pages
288
Format
Paperback
Dimensions
25.4 x 17.8 x 1.5 cm
Weight
0.50 kg.
ISBN
1461285305
ISBN13
9781461285304

peritoneal carcinomatosis: drugs and diseases

Paul H. Sugarbaker (Illustrated by) · Springer · Paperback

peritoneal carcinomatosis: drugs and diseases - Sugarbaker, Paul H.

New Book

£ 227.74

  • Condition: New
Origin: U.S.A. (Import costs included in the price)
It will be shipped from our warehouse between Monday, June 17 and Wednesday, July 03.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.

Synopsis "peritoneal carcinomatosis: drugs and diseases"

Peritoneal carcinomatosis dominates the clinical picture of many patients with gastrointestinal, gynecological and urological cancers. For many of them its dev- astating effects contribute directly to their death. Most clinicians consider peritoneal carcinomatosis an incurable metastatic disease and give palliative treatment, re- stricted to limited surgery and systemic chemotherapy. Contrary to this view, Paul Sugarbaker and his collegues base their approach on the concept that peritoneal carcinomatosis represents regional tumor spread, similar in its impact on treatment and prognosis to that of lymph node metastases in other malignancies. This concept emphasises the value of regional tumor control, as a potentially curative measure. In this book the combination of aggressive cytoreduction and intraperitoneal chemotherapy to control peritoneal carcinomatosis is extensively explored. Basic to this approach is the observation that most cancer cells show only relative resistence against commonly available drugs, which can be overcome by a sufficient increase of drug concentrations in tumor tissue. After intraperitoneal delivery, drugs will reach high tissue concentrations in the superficial few cell layers, while plasma concentrations will remain below toxic levels. Patients with only limited residual tumor at the peritoneal surface after cytoreduction may therefore benefit from intraperitoneal chemotherapy.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews